<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-viruses-11-00678">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rudge</surname>
    <given-names>T.L.</given-names>
    <suffix>Jr.</suffix>
   </name>
   <name>
    <surname>Sankovich</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Niemuth</surname>
    <given-names>N.A.</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Badorrek</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Skomrock</surname>
    <given-names>N.D.</given-names>
   </name>
   <name>
    <surname>Cirimotich</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Carol</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Sabourin</surname>
    <given-names>C.L.</given-names>
   </name>
  </person-group>
  <article-title>Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples</article-title>
  <source>PLoS ONE</source>
  <year>2019</year>
  <volume>14</volume>
  <elocation-id>e0215457</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0215457</pub-id>
  <?supplied-pmid 30998735?>
  <pub-id pub-id-type="pmid">30998735</pub-id>
 </element-citation>
</ref>
